207 related articles for article (PubMed ID: 28763836)
1. [Early imaging diagnosis of primary liver cancer].
Long LL; Peng P; Huang ZK
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):329-332. PubMed ID: 28763836
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
[TBL] [Abstract][Full Text] [Related]
3. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.
Hennedige T; Venkatesh SK
World J Gastroenterol; 2016 Jan; 22(1):205-20. PubMed ID: 26755871
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
[TBL] [Abstract][Full Text] [Related]
6. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
[TBL] [Abstract][Full Text] [Related]
10. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
11. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma.
Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H
Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of Magnetic Resonance Imaging using liver tissue specific contrast agents and contrast enhanced Multi Detector Computed Tomography: A systematic review of diagnostic test in Hepatocellular Carcinoma (HCC).
Usman S; Smith L; Brown N; Major V
Radiography (Lond); 2018 Nov; 24(4):e109-e114. PubMed ID: 30292515
[TBL] [Abstract][Full Text] [Related]
14. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
[TBL] [Abstract][Full Text] [Related]
15. Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art.
Zech CJ; Reiser MF; Herrmann KA
Dig Dis; 2009; 27(2):114-24. PubMed ID: 19546549
[TBL] [Abstract][Full Text] [Related]
16. Imaging of hepatocellular carcinoma: current concepts.
Parikh A; Taouli B
Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
[TBL] [Abstract][Full Text] [Related]
17. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic imaging for the screening of hepatocellular carcinoma].
Jakab Z
Orv Hetil; 2010 Jul; 151(27):1083-90. PubMed ID: 20558357
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
20. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.
Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H
Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
